Daniel Gamba
Known title: Co-President, Chief CommercialCIK: 0001972227
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Northern Trust Q3 Earnings Loom Amid Mixed Sector News. Northern Trust is approaching its third-quarter earnings release, with analysts focusing on revenue and EPS estimates. Recent reports indicate the stock has experienced a sharp decline, joining other financial peers in a downturn. While one firm reaffirmed a positive outlook citing the company's quality, the broader sector remains under pressure.
Transaction History
| BEN | ▼ Sell | Tax Withholding | 64,136 | $2.2M | 8/31/2026 | View on chart |
| BEN | ▲ Buy | Grant | 229,850 | $7.5M | 7/21/2026 | View on chart |
| BEN | ▲ Buy | Grant | 442,870 | $10.1M | 10/15/2025 | View on chart |
| NTRS | ▼ Sell | Tax Withholding | 6,061 | $560K | 4/3/2025 | View on chart |
| NTRS | ▼ Sell | Tax Withholding | 1,300 | $143K | 3/1/2025 | View on chart |
| NTRS | ▲ Buy | Grant | 8,819 | $0 | 2/5/2025 | View on chart |
| NTRS | ▼ Sell | Tax Withholding | 6,061 | $532K | 4/3/2024 | View on chart |
| NTRS | ▲ Buy | Grant | 11,731 | $0 | 2/21/2024 | View on chart |
| NTRS | ▲ Buy | Grant | 54,720 | $0 | 4/3/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Barclays cuts Franklin Templeton price target to $34
Barclays lowered its price target for Franklin Templeton to $34 while keeping an Equal-Weight rating. This follows recent news about the firm expanding its asset-backed finance capabilities with Benefit Street Partners. The stock is currently trading near its 52-week low, with an average analyst target of $35.46.
Barclays cuts Franklin Templeton price target to $34. Barclays lowered its price target for Franklin Templeton to $34 while keeping an Equal-Weight rating. This follows recent news about the firm expanding its asset-backed finance capabilities with Benefit Street Partners. The stock is currently trading near its 52-week low, with an average analyst target of $35.46.